AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionSimon Quick Advisors, Llc
Latest Disclosed Ownership6,743 shares
Latest Disclosed Value $ 1,466,535
Simon Quick Advisors, Llc reports 10.09% decrease in ownership of 4AB / AbbVie Inc.

On May 6, 2026 - Simon Quick Advisors, Llc filed a 13F-HR form disclosing ownership of 6,743 shares of AbbVie Inc. (DE:4AB) valued at $1,250,152 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 7,500 shares of AbbVie Inc.. This represents a change in shares of -10.09% during the quarter. The current value of the position is $1,271,056 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 6,743 -757 -10.09 1,467 -14.42 0.0671
2026-01-29 2025-12-31 13F ABBVIE COM 00287Y109 7,500 373 5.23 1,714 3.82 0.0748
2025-10-21 2025-09-30 13F ABBVIE COM 00287Y109 7,127 594 9.09 1,650 36.14 0.0746
2025-10-08 2025-06-30 13F/A-1 ABBVIE COM 00287Y109 6,533 -15,172 -69.90 1,213 -73.35 0.0614
2025-08-04 2025-06-30 13F ABBVIE COM 00287Y109 25,910 4,205 4,809 0.1935
2025-04-15 2025-03-31 13F ABBVIE COM 00287Y109 21,705 2,688 14.13 4,548 34.57 0.2588
2025-01-17 2024-12-31 13F ABBVIE COM 00287Y109 19,017 8,238 76.43 3,379 58.79 0.2024
2024-10-15 2024-09-30 13F ABBVIE COM 00287Y109 10,779 1,607 17.52 2,129 35.28 0.1345
2024-08-02 2024-06-30 13F ABBVIE COM 00287Y109 9,172 1,540 20.18 1,573 13.25 0.1111
2024-04-19 2024-03-31 13F ABBVIE COM 00287Y109 7,632 1,333 21.16 1,390 42.32 0.1041
2024-01-16 2023-12-31 13F ABBVIE COM 00287Y109 6,299 -503 -7.39 976 -3.65 0.0863
2023-10-24 2023-09-30 13F ABBVIE COM 00287Y109 6,802 1,032 17.89 1,014 30.37 0.0956
2023-08-01 2023-06-30 13F ABBVIE COM 00287Y109 5,770 -1,195 -17.16 777 -30.00 0.0718
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 6,965 935 15.51 1,110 13.96 0.1203
2023-01-30 2022-12-31 13F ABBVIE COM 00287Y109 6,030 1,717 39.81 974 68.22 0.1156
2022-11-07 2022-09-30 13F ABBVIE COM 00287Y109 4,313 164 3.95 579 1.05 0.0818
2022-08-08 2022-06-30 13F ABBVIE COM 00287Y109 4,149 1,277 44.46 573 22.96 0.0750
2022-05-05 2022-03-31 13F AbbVie COM 00287Y109 2,872 -808 -21.96 466 -6.43 0.1321
2022-02-08 2021-12-31 13F AbbVie COM 00287Y109 3,680 344 10.31 498 38.72 0.1331
2021-10-27 2021-09-30 13F AbbVie COM 00287Y109 3,336 229 7.37 359 2.57 0.0923
2021-07-21 2021-06-30 13F AbbVie COM 00287Y109 3,107 45 1.47 350 5.74 0.0926
2021-05-06 2021-03-31 13F AbbVie COM 00287Y109 3,062 1,035 51.06 331 52.53 0.0974
2021-01-27 2020-12-31 13F AbbVie COM 00287Y109 2,027 1,405 225.88 217 301.85 0.0655
2020-10-26 2020-09-30 13F AbbVie COM 00287Y109 622 -92 -12.89 54 -22.86 0.0154
2020-08-04 2020-06-30 13F AbbVie COM 00287Y109 714 -120 -14.39 70 9.38 0.0265
2020-04-09 2020-03-31 13F AbbVie COM 00287Y109 834 234 39.00 64 20.75 0.0237
2020-01-06 2019-12-31 13F AbbVie COM 00287Y109 600 -25 -4.00 53 12.77 0.0192
2019-10-16 2019-09-30 13F AbbVie COM 00287Y109 625 600 2,400.00 47 4,600.00 0.0208
2019-08-05 2019-06-30 13F AbbVie COM 00287Y109 25 25 2 0.0009
2019-04-16 2019-03-31 13F ABBVIE COM 00287Y109 0 -693 -100.00 0 -100.00
2019-01-29 2018-12-31 13F ABBVIE COM 00287Y109 693 693 64 0.0233
2018-10-29 2018-09-30 13F ABBVIE COM 00287Y109 0 -93 -100.00 0 -100.00
2018-08-10 2018-06-30 13F ABBVIE COM 00287Y109 93 93 8 0.0034
2018-05-07 2018-03-31 13F AbbVie COM 00287Y109 0 -950 -100.00 0 -100.00
2018-04-10 2017-12-31 13F/A-1 AbbVie COM 00287Y109 950 300 46.15 107 84.48 0.0477
2018-02-13 2017-12-31 13F AbbVie COM 00287Y109 950 300 107 0.0426
2017-11-06 2017-09-30 13F ABBVIE INC COM USD001 COM 00287Y109 650 0 0.00 58 23.40 0.0210
2017-08-11 2017-06-30 13F ABBVIE COM 00287Y109 650 -777 -54.45 47 -49.46 0.0265
2017-05-15 2017-03-31 13F/A-1 ABBVIE COM 00287Y109 1,427 -1,395 -49.43 93 -47.46 0.0551
2017-05-11 2017-03-31 13F AbbVie Stock 00287Y109 1,427 -1,395 93 0.0629
2017-01-24 2016-12-31 13F AbbVie COM 00287Y109 2,822 2,822 177 0.1322
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.